The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is a non-profit international organization with headquarters in Basel, Switzerland.

The Assembly of Members takes place at the annual ECCMID, which serves as a forum for discussion and resolution of professional matters of common interest.

[1][6] ESCMID also promotes the development and dissemination of clinical and laboratory practice guidelines according to the principles of evidence-based medicine, to harmonize European diagnostic, therapeutic, and infection control procedures.

Examples of recently published documents focused on drug treatment and clinical management of COVID-19,[7] Lyme disease,[8] Sepsis,[9] Clostridioides difficile infection.

Clinical Microbiology and Infection (CMI) is the official peer-reviewed ESCMID publication, which publishes monthly issues and additional supplements devoted to special themes.

The ESCMID Parity Commission was founded to review and improve representation of minorities as well as gender and geographical balance in the society's fields of expertise.

[5] ESCMID supports young clinicians and researchers as well as established scholars with awards and grants to acknowledge past achievements and provide an incentive for future accomplishments.